The roles of αV integrins in lens EMT and posterior capsular opacification

Journal of Cellular and Molecular Medicine

Volumn 18, Issue 4, 2014, Pages 656-670

  Mamuya, Fahmy A ^a   Wang, Yan ^a   Roop, Victoria H ^a   Scheiblin, David A ^a   Zajac, Jocelyn C ^a   Duncan, Melinda K ^a  

^a UNIVERSITY OF DELAWARE   (United States)

Author keywords

Epithelial to mesenchymal transition; Fibrosis; Integrins; Lens; Posterior capsular opacification; Secondary cataract; Transforming growth factor beta; Wound healing response

Indexed keywords

ACTIN; ALPHA-SMOOTH MUSCLE ACTIN, MOUSE; CD51 ANTIGEN; SMAD3 PROTEIN; SMAD3 PROTEIN, MOUSE; TRANSFORMING GROWTH FACTOR BETA;

ADVERSE EFFECTS; ANIMAL; BIOSYNTHESIS; CAPSULE OPACIFICATION; CATARACT EXTRACTION; CELL PROLIFERATION; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; LENS CAPSULE; METABOLISM; MOUSE; MYOFIBROBLAST; PATHOLOGY; WOUND HEALING;

ACTINS; ANIMALS; CAPSULE OPACIFICATION; CATARACT EXTRACTION; CELL PROLIFERATION; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; INTEGRIN ALPHAV; LENS CAPSULE, CRYSTALLINE; MICE; MYOFIBROBLASTS; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; WOUND HEALING;

EID: 84897962195     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12213     Document Type: Article

References (74)

1. Asbell PA, Dualan I, Mindel J, et al. Age-related cataract. Lancet. 2005; 365: 599-609.
2. World Health Organization. Global initiative for the elimination of blindness. WHO/PBL. 2008; 97.61. Rev.1.
3. Steinberg EP, Javitt JC, Sharkey PD, et al. The content and cost of cataract surgery. Arch Ophthalmol. 1993; 111: 1041-9.
4. Laroche L. actuality in cataract treatment. Rev Prat. 2013; 63: 43-7.
5. Foster A. Cataract and "vision 2020-the right to sight" initiative. Br J Ophthalmol. 2001; 85: 635-7.
6. Apple DJ, Escobar-Gomez M, Zaugg B, et al. Modern cataract surgery: unfinished business and unanswered questions. Surv Ophthalmol. 2011; 56: S3-53.
7. de Iongh RU, Wederell E, Lovicu FJ, et al. Transforming growth factor-beta-induced epithelial-mesenchymal transition in the lens: a model for cataract formation. Cells Tissues Organs. 2005; 179: 43-55.
8. Wormstone IM, Wang L, Liu CSC. Posterior capsule opacification. Exp Eye Res. 2009; 88: 257-69.
9. Werner L, Tassignon MJ, Zaugg BE, et al. Clinical and histopathologic evaluation of six human eyes implanted with the bag-in-the-lens. Ophthalmology. 2010; 117: 55-62.
10. Awasthi N, Guo S, Wagner BJ. Posterior capsular opacification: a problem reduced but not yet eradicated. Arch Ophthalmol. 2009; 127: 555-62.
11. Dewey S. Posterior capsule opacification. Curr Opin Ophthalmol. 2006; 17: 45-53.
12. Hales AM, Schulz MW, Chamberlain CG, et al. TGF-β1 induces lens cells to accumulate alpha-smooth muscle actin, a marker for subcapsular cataracts. Curr Eye Res. 1994; 13: 885-90.
13. Cousins SW, McCabe MM, Danielpour D, et al. Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor. Invest Ophthalmol Vis Sci. 1991; 32: 2201-11.
14. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 1992; 69: 11-25.
15. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell. 2002; 110: 673-87.
16. Simirskii VN, Wang Y, Duncan MK. Conditional deletion of beta1-integrin from the developing lens leads to loss of the lens epithelial phenotype. Dev Biol. 2007; 306: 658-68.
17. Walker J, Menko AS. Integrins in lens development and disease. Exp Eye Res. 2009; 88: 216-25.
18. Sponer U, Pieh S, Soleiman A, et al. Upregulation of alphavbeta6 integrin, a potent TGF-β1 activator, and posterior capsule opacification. J Cataract Refract Surg. 2005; 31: 595-606.
19. Zuk A, Hay ED. Expression of beta 1 integrins changes during transformation of avian lens epithelium to mesenchyme in collagen gels. Dev Dyn. 1994; 201: 378-93.
20. Barbour WK, Saika S, Miyamoto T, Ohkawa K, et al. Expression patterns of beta1-related alpha integrin subunits in murine lens during embryonic development and wound healing. Curr Eye Res. 2004; 29: 1-10.
21. Nemeth JA, Nakada MT, Trikha M, et al. Alpha-v integrins as therapeutic targets in oncology. Cancer Invest. 2007; 25: 632-46.
22. McCarty JH, Lacy-Hulbert A, Charest A, et al. Selective ablation of alphav integrins in the central nervous system leads to cerebral hemorrhage, seizures, axonal degeneration and premature death. Development. 2005; 132: 165-76.
23. Zhao H, Yang Y, Rizo CM, et al. Insertion of a pax6 consensus binding site into the AlphaA-crystallin promoter acts as a lens epithelial cell enhancer in transgenic mice. Invest Ophthalmol Vis Sci. 2004; 45: 1930-9.
24. Lakso M, Pichel JG, Gorman JR, et al. Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc Natl Acad Sci USA. 1996; 93: 5860-5.
25. Shiels A, King JM, Mackay DS, et al. Refractive defects and cataracts in mice lacking lens intrinsic membrane protein-2. Invest Ophthalmol Vis Sci. 2007; 48: 500-8.
26. Duncan MK, Cui W, Oh DJ, Tomarev SI. Prox1 is differentially localized during lens development. Mech Dev. 2002; 112: 195-8.
27. Scheiblina DA, Gaob J, Caplana JL, et al. Beta-1 integrin is important for the structural maintenance and homeostasis of differentiating fiber cells 2014. (Submitted)
28. Desai VD, Wang Y, Simirskii VN, et al. Cd44 expression is developmentally regulated in the mouse lens and increases in the lens epithelium after injury. Differentiation. 2010; 79: 111-9.
29. Call MK, Grogg MW, Del Rio-Tsonis K, et al. Lens regeneration in mice: implications in cataracts. Exp Eye Res. 2004; 78: 297-9.
30. Reed NA, Oh D-J, Czymmek KJ, et al. An immunohistochemical method for the detection of proteins in the vertebrate lens. J Immunol Methods. 2001; 253: 243-52.
31. Kotogany E, Dudits D, Horvath G, et al. A rapid and robust assay for detection of s-phase cell cycle progression in plant cells and tissues by using ethynyl deoxyuridine. Plant Methods. 2010; 6: 5.
32. Warren M, Puskarczyk K, Chapman S. Chick embryo proliferation studies using edu labeling. Dev Dyn. 2009; 238: 944-9.
33. Valastyan S, Reinhardt F, Benaich N, et al. A pleiotropically acting microrna, mir-31, inhibits breast cancer metastasis. Cell. 2009; 137: 1032-46.
34. Augoff K, Das M, Bialkowska K, et al. Mir-31 is a broad regulator of beta1-integrin expression and function in cancer cells. Mol Cancer Res. 2011; 9: 1500-8.
35. Tanaka S, Saika S, Ohmi S, et al. Cellular fibronectin, but not collagens, disappears in the central posterior capsules during healing after lens extraction and iol implantation in rabbits. Jpn J Ophthalmol. 2002; 46: 147-52.
36. Tanaka S, Sumioka T, Fujita N, et al. Suppression of injury-induced epithelial-mesenchymal transition in a mouse lens epithelium lacking tenascin-c. Mol Vis. 2010; 16: 1194-205.
37. Eldred JA, Dawes LJ, Wormstone IM. The lens as a model for fibrotic disease. Philos Trans R Soc Lond B Biol Sci. 2011; 366: 1301-19.
38. Gwon A. Lens regeneration in mammals: a review. Surv Ophthalmol. 2006; 51: 51-62.
39. Saika S, Kono-Saika S, Ohnishi Y, et al. Smad3 signaling is required for epithelial-mesenchymal transition of lens epithelium after injury. Am J Pathol. 2004; 164: 651-63.
40. Nam JO, Kim JE, Jeong HW, et al. Identification of the alphavbeta3 integrin-interacting motif of betaig-h3 and its anti-angiogenic effect. J Biol Chem. 2003; 278: 25902-9.
41. Jeon ES, Kim JH, Ryu H, et al. Lysophosphatidic acid activates tgfbip expression in human corneal fibroblasts through a TGF-β1-dependent pathway. Cell Signal. 2012; 24: 1241-50.
42. De Arcangelis A, Mark M, Kreidberg J, et al. Synergistic activities of alpha3 and alpha6 integrins are required during apical ectodermal ridge formation and organogenesis in the mouse. Development. 1999; 126: 3957-68.
43. Shiels A, Bassnett S, Varadaraj K, et al. Optical dysfunction of the crystalline lens in aquaporin-0-deficient mice. Physiol Genomics. 2001; 7: 179-86.
44. Kerr JS, Slee AM, Mousa SA. The alpha(v) integrin antagonists as novel anticancer agents: an update. Expert Opin Inv Drug. 2002; 11: 1765-74.
45. Dawes LJ, Elliott RM, Reddan JR, et al. Oligonucleotide microarray analysis of human lens epithelial cells: TGF-β regulated gene expression. Mol Vis. 2007; 13: 1181-97.
46. Sossey-Alaoui K, Downs-Kelly E, Das M, et al. Wave3, an actin remodeling protein, is regulated by the metastasis suppressor microrna, mir-31, during the invasion-metastasis cascade. Int J Cancer. 2011; 129: 1331-43.
47. Karali M, Peluso I, Gennarino VA, et al. Mirneye: a microrna expression atlas of the mouse eye. Bmc Genomics. 2010; 11: 715.
48. van Bree MC, van der Meulen IJ, Franssen L, et al. Imaging of forward light-scatter by opacified posterior capsules isolated from pseudophakic donor eyes. Invest Ophthalmol Vis Sci. 2011; 52: 5587-97.
49. Huang YS, Xie LX. Lens fiber differentiation in rats posterior capsule opacification. Zhonghua Yan Ke Za Zhi. 2007; 43: 260-5.
50. Kappelhof J, Vrensen G, Jong P, et al. The ring of soemmerring in man: an ultrastructural study. Graefes Arch Clin Exp Ophthalmol. 1987; 225: 77-83.
51. Marcantonio JM, Vrensen GF. Cell biology of posterior capsular opacification. Eye (Lond). 1999; 13(Pt 3b): 484-8.
52. Dawes LJ, Sleeman MA, Anderson IK, et al. TGF-β/smad4-dependent and -independent regulation of human lens epithelial cells. Invest Ophthalmol Vis Sci. 2009; 50: 5318-27.
53. Lovicu FJ, Schulz MW, Hales AM, et al. TGF-β induces morphological and molecular changes similar to human anterior subcapsular cataract. Br J Ophthalmol. 2002; 86: 220-6.
54. Saika S, Okada Y, Miyamoto T, et al. Smad translocation and growth suppression in lens epithelial cells by endogenous TGF-β2 during wound repair. Exp Eye Res. 2001; 72: 679-86.
55. Saika S, Miyamoto T, Ishida I, et al. TGF-β-smad signalling in postoperative human lens epithelial cells. Br J Ophthalmol. 2002; 86: 1428-33.
56. Lee EH, Joo C-K. Role of transforming growth factor-β in transdifferentiation and fibrosis of lens epithelial cells. Invest Ophthalmol Vis Sci. 1999; 40: 2025-32.
57. Wipff P-J, Rifkin DB, Meister J-J, et al. Myofibroblast contraction activates latent TGF-β1 from the extracellular matrix. J Cell Biol. 2007; 179: 1311-23.
58. Wipff P-J, Hinz B. Integrins and the activation of latent transforming growth factor [beta]1 - an intimate relationship. Eur J Cell Biol. 2008; 87: 601-15.
59. V integrins and TGF-β-induced EMT: a circle of regulation. J Cell Mol Med. 2012; 16: 445-55.
60. Munger JS, Huang X, Kawakatsu H, et al. A mechanism for regulating pulmonary inflammation and fibrosis: the integrin [alpha]v[beta]6 binds and activates latent TGF-β1. Cell. 1999; 96: 319-28.
61. Annes JP, Rifkin DB, Munger JS. The integrin [alpha]v[beta]6 binds and activates latent tgf[beta]3. FEBS Lett. 2002; 511: 65-8.
62. Annes JP, Chen Y, Munger JS, et al. Integrin [alpha]v[beta]6-mediated activation of latent TGF-β requires the latent TGF-β binding protein-1. J Cell Biol. 2004; 165: 723-34.
63. Ludbrook SB, Barry ST, Delves CJ, et al. The integrin alphavbeta3 is a receptor for the latency-associated peptides of transforming growth factors beta1 and beta3. Biochem J. 2003; 369: 311-8.
64. Brooks PC, Stromblad S, Sanders LC, et al. Localization of matrix metalloproteinase mmp-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell. 1996; 85: 683-93.
65. Rolli M, Fransvea E, Pilch J, et al. Activated integrin αvβ3 cooperates with metalloproteinase mmp-9 in regulating migration of metastatic breast cancer cells. Proc Natl Acad Sci USA. 2003; 100: 9482-7.
66. Mu D, Cambier S, Fjellbirkeland L, et al. The integrin αvβ8 mediates epithelial homeostasis through mt1-mmp-dependent activation of TGF-β1. J Cell Biol. 2002; 157: 493-507.
67. West-Mays JA, Pino G. Matrix metalloproteinases as mediators of primary and secondary cataracts. Expert Rev Ophthalmol. 2007; 2: 931-8.
68. Cary LA, Han DC, Guan JL. Integrin-mediated signal transduction pathways. Histol Histopathol. 1999; 14: 1001-9.
69. Dedhar S. Integrins and signal transduction. Curr Opin Hematol. 1999; 6: 37-43.
70. Zhang YE. Non-smad pathways in tgf-beta signaling. Cell Res. 2009; 19: 128-39.
71. Rivera LB, Brekken RA. Sparc promotes pericyte recruitment via inhibition of endoglin-dependent TGF-β1 activity. J Cell Biol. 2011; 193: 1305-19.
72. Guo W, Giancotti FG. Integrin signalling during tumour progression. Nat Rev Mol Cell Biol. 2004; 5: 816-26.
73. Galliher A, Schiemann W. Beta3 integrin and src facilitate transforming growth factor-beta mediated induction of epithelial-mesenchymal transition in mammary epithelial cells. Breast Cancer Res. 2006; 8: R42.
74. Playford MP, Schaller MD. The interplay between src and integrins in normal and tumor biology. Oncogene. 2004; 23: 7928-46.